z-logo
open-access-imgOpen Access
Mutated Response Regulator graR Is Responsible for Phenotypic Conversion of Staphylococcus aureus from Heterogeneous Vancomycin-Intermediate Resistance to Vancomycin-Intermediate Resistance
Author(s) -
Huimin Neoh,
Longzhu Cui,
Hiroko Yuzawa,
Fumihiko Takeuchi,
Miki Matsuo,
Kazumasa Hiramatsu
Publication year - 2008
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00534-07
Subject(s) - vancomycin , daptomycin , staphylococcus aureus , microbiology and biotechnology , phenotype , biology , methicillin resistant staphylococcus aureus , strain (injury) , regulator , drug resistance , genetics , gene , bacteria , anatomy
Multistep genetic alteration is required for methicillin-resistantStaphylococcus aureus (MRSA) to achieve the level of vancomycin resistance of vancomycin-intermediateS. aureus (VISA). In the progression of vancomycin resistance, strains with heterogeneous vancomycin resistance, designated hetero-VISA, are observed. In studying the whole-genome sequencing of the representative hetero-VISA strain Mu3 and comparing it with that of closely related MRSA strains Mu50 (VISA) and N315 (vancomycin-susceptibleS. aureus [VSSA]), we identified a mutation in the response regulator of thegraSR two-component regulatory system. Introduction of mutatedgraR , designatedgraR *, but not intactgraR , designatedgraRn , could convert the hetero-VISA phenotype of Mu3 into a VISA phenotype which was comparable to that of Mu50. The same procedure did not appreciably increase the vancomycin resistance of VSSA strain N315, indicating thatgraR * expression was effective only in the physiological milieu of hetero-VISA cell to achieve a VISA phenotype. Interestingly, the overexpression ofgraR * increased the daptomycin MICs in both Mu3 and N315 and decreased the oxacillin MIC in N315.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here